SG11201805114RA - Method for manufacturing a drug delivery device and a drug delivery device manufactured according to the method - Google Patents

Method for manufacturing a drug delivery device and a drug delivery device manufactured according to the method

Info

Publication number
SG11201805114RA
SG11201805114RA SG11201805114RA SG11201805114RA SG11201805114RA SG 11201805114R A SG11201805114R A SG 11201805114RA SG 11201805114R A SG11201805114R A SG 11201805114RA SG 11201805114R A SG11201805114R A SG 11201805114RA SG 11201805114R A SG11201805114R A SG 11201805114RA
Authority
SG
Singapore
Prior art keywords
international
delivery device
drug delivery
turku
pct
Prior art date
Application number
SG11201805114RA
Other languages
English (en)
Inventor
Svante Holmberg
Heikki Lyytikäinen
Christine Talling
Saara Ruotsalainen
Petri Laakso
Original Assignee
Bayer Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Oy filed Critical Bayer Oy
Publication of SG11201805114RA publication Critical patent/SG11201805114RA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/08—Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
    • A61F6/142—Wirelike structures, e.g. loops, rings, spirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/14—Female reproductive, genital organs
    • A61M2210/1475—Vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Lining Or Joining Of Plastics Or The Like (AREA)
SG11201805114RA 2015-12-21 2016-12-19 Method for manufacturing a drug delivery device and a drug delivery device manufactured according to the method SG11201805114RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15201533 2015-12-21
PCT/EP2016/081715 WO2017108676A1 (fr) 2015-12-21 2016-12-19 Procédé de fabrication d'un dispositif d'administration de médicament, et dispositif d'administration de médicament fabriqué à l'aide du procédé

Publications (1)

Publication Number Publication Date
SG11201805114RA true SG11201805114RA (en) 2018-07-30

Family

ID=55024876

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201805114RA SG11201805114RA (en) 2015-12-21 2016-12-19 Method for manufacturing a drug delivery device and a drug delivery device manufactured according to the method

Country Status (23)

Country Link
US (1) US11007140B2 (fr)
EP (1) EP3393452B1 (fr)
JP (1) JP6936801B2 (fr)
KR (1) KR20180103071A (fr)
CN (1) CN108430453B (fr)
AR (1) AR107098A1 (fr)
AU (1) AU2016375432A1 (fr)
BR (1) BR112018012743A2 (fr)
CA (1) CA3008941C (fr)
CL (1) CL2018001691A1 (fr)
CO (1) CO2018006393A2 (fr)
HK (1) HK1257934A1 (fr)
IL (1) IL259343A (fr)
JO (1) JOP20160267B1 (fr)
MX (1) MX2018007675A (fr)
MY (1) MY193641A (fr)
PE (1) PE20181214A1 (fr)
RU (1) RU2732822C2 (fr)
SG (1) SG11201805114RA (fr)
TW (1) TWI726956B (fr)
UA (1) UA124382C2 (fr)
UY (1) UY37043A (fr)
WO (1) WO2017108676A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20211195A1 (es) 2017-09-27 2021-07-01 Bayer Oy Un metodo para modificar la liberacion de un agente terapeuticamente activo de una matriz elastomerica

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4292965A (en) * 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
FR2618329B1 (fr) * 1987-07-22 1997-03-28 Dow Corning Sa Procede de fabrication d'un anneau capable d'assurer la liberation d'un agent therapeutique, et anneau fabrique par ce procede
US6846852B2 (en) * 2001-08-16 2005-01-25 Goldschmidt Ag Siloxane-containing compositions curable by radiation to silicone elastomers
CN1403172A (zh) * 2001-09-07 2003-03-19 上海市计划生育科学研究所 一种用于治疗妇女更年期综合症的药物控释装置
CN1264488C (zh) * 2003-05-14 2006-07-19 上海市计划生育科学研究所 阴道环简易制备方法
DK2010096T3 (en) * 2006-03-31 2017-10-02 Mati Therapeutics Inc NASOLACRIMAL DRAINAGE SYSTEM IMPLANTS FOR PHARMACEUTICAL THERAPY
US20070260300A1 (en) * 2006-05-04 2007-11-08 Daniel Gregorich Intraluminal medical device having a curable coating
TW200930343A (en) * 2007-09-21 2009-07-16 Organon Nv Drug delivery system
TW200927141A (en) * 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
EP2140860A1 (fr) * 2008-07-03 2010-01-06 Bayer Schering Pharma Oy Procédé de contraception amélioré
EP2636705B1 (fr) * 2008-10-29 2018-12-19 3M Innovative Properties Company Adhésifs sensibles à la pression de silicone non-fonctionnalisée, durci par faisceau d'électrons
FI121000B (fi) * 2008-11-19 2010-06-15 Bayer Schering Pharma Oy Intravaginaalinen antojärjestelmä ja menetelmä sen valmistamiseksi
US8212934B2 (en) * 2009-02-19 2012-07-03 Sony Corporation Method for processing an analog television signal
FI20095563A (fi) * 2009-05-20 2010-11-21 Bayer Schering Pharma Oy Vaginaalinen antojärjestelmä
AU2010274946B2 (en) * 2009-07-21 2013-09-12 The Population Council, Inc. Multi-layered gradient vaginal ring
DE102010003494A1 (de) * 2010-03-31 2011-10-06 Bayer Schering Pharma Aktiengesellschaft Parenterales Abgabesystem, das Aromatasehemmer und Gestagene freisetzt, für die Behandlung von Endometriose
MX2013002016A (es) * 2010-08-20 2013-03-25 Teva Womens Health Inc Dispositivos intravaginales, metodos de fabricacion y usos de los mismos.
US20120057219A1 (en) * 2010-09-07 2012-03-08 Panasonic Corporation Laser light source apparatus
AU2012268068B2 (en) * 2011-06-06 2016-10-13 Auritec Pharmaceuticals Drug delivery device employing wicking release window
BR112014028725A8 (pt) * 2012-05-18 2019-01-29 3M Innovative Properties Co artigo adesivo, construções adesivas e métodos para preparar uma construção adesiva
EP2931813B1 (fr) * 2012-12-12 2020-08-05 3M Innovative Properties Company Gels à base de siloxane durcissables à température ambiante
JP6657897B2 (ja) * 2015-12-10 2020-03-04 株式会社リコー ミラー部材の加工方法

Also Published As

Publication number Publication date
JP6936801B2 (ja) 2021-09-22
KR20180103071A (ko) 2018-09-18
US20190000751A1 (en) 2019-01-03
CN108430453B (zh) 2023-03-17
MY193641A (en) 2022-10-21
CO2018006393A2 (es) 2018-07-10
CA3008941A1 (fr) 2017-06-29
EP3393452A1 (fr) 2018-10-31
RU2018126720A3 (fr) 2020-04-06
AU2016375432A1 (en) 2018-06-14
JP2019502702A (ja) 2019-01-31
TWI726956B (zh) 2021-05-11
RU2732822C2 (ru) 2020-09-22
US11007140B2 (en) 2021-05-18
UA124382C2 (uk) 2021-09-08
PE20181214A1 (es) 2018-07-24
CL2018001691A1 (es) 2018-10-05
MX2018007675A (es) 2018-09-12
TW201726069A (zh) 2017-08-01
RU2018126720A (ru) 2020-01-24
CA3008941C (fr) 2024-01-02
BR112018012743A2 (pt) 2018-12-04
IL259343A (en) 2018-07-31
EP3393452B1 (fr) 2021-08-04
WO2017108676A1 (fr) 2017-06-29
UY37043A (es) 2017-07-31
AR107098A1 (es) 2018-03-21
CN108430453A (zh) 2018-08-21
JOP20160267B1 (ar) 2021-08-17
HK1257934A1 (zh) 2019-11-01

Similar Documents

Publication Publication Date Title
SG11201811431VA (en) Multispecific antibodies against cd40 and cd137
SG11201906431UA (en) Method for the treatment of thromboembolism
SG11201909371PA (en) Composite dressings for improved granulation and reduced maceration with negative-pressure treatment
SG11201808622SA (en) Chimeric receptors to flt3 and methods of use thereof
SG11201808125RA (en) Methods for solid tumor treatment
SG11201807912SA (en) Vaccine against rsv
SG11201807913XA (en) Stabilized soluble pre-fusion rsv f proteins
SG11201808476SA (en) Recycling of polymer matrix composite
SG11201808108XA (en) Synthesis of indazoles
SG11201806342SA (en) Glucagon and glp-1 co-agonists for the treatment of obesity
SG11201408605UA (en) Methods for biodegradable derivatization of cellulosic surfaces
SG11201407200TA (en) Liquid formulation
SG11201807827VA (en) Process for the preparation of pegylated drug-linkers and intermediates thereof
SG11201805001UA (en) Method of treating influenza a
SG11201809534UA (en) Methods of treating autoimmune disease using allogeneic t cells
SG11201805311XA (en) Method of treating a mammal, including human, against cancer using methionine and asparagine depletion
SG11201900361RA (en) Methods of treating prostate cancer
SG11201901063SA (en) Therapeutic agents for neurodegenerative diseases
SG11201804821PA (en) A beverage capsule
SG11201804587QA (en) Isoindole compounds
SG11201810078PA (en) Stabilized pre-fusion rsv f proteins
SG11201901986SA (en) Process for the manufacture of a solid pharmaceutical adminstration form
SG11201809882XA (en) Pharmaceutical combinations for treating cancer
SG11201408509PA (en) Racecadotril lipid compositions
SG11201804220SA (en) Activated stem cells and systemic treatment methods for infected wounds